ERG Acquires Industry Leading Alzheimer’s Research Site, Brain Matters Research

I could not be happier to be welcomed into the ERG portfolio of quality research units.”
— Dr. Mark Brody

WATCHUNG, NJ, UNITED STATES, November 3, 2017 / -- Evolution Research Group, LLC (ERG) is proud to announce the acquisition of Brain Matters Research of Delray Beach, Florida. Brain Matters Research (BMR) was founded by Dr. Mark Brody, a neurologist and nationally recognized expert in Alzheimer’s disease and stroke research. He is a former Professor of Neurology at University of California, San Diego and Stroke Program Director at Scripps, La Jolla who relocated to Palm Beach County in 1995. In addition to caring for his patients, Dr. Brody has dedicated the last 20 years to working closely with the pharmaceutical and biotechnology industries to investigate new treatments for stroke, Alzheimer’s disease, mild cognitive impairment (MCI) and other types of dementia.

Dr. Brody is excited about joining Evolution Research Group stating, “I could not be happier to be welcomed into the ERG portfolio of quality research units. ERG’s leading position in the field of neuroscience, strong infrastructure, experienced team of clinical and operational experts, dedication to quality and strong, and long-standing relationships within the industry made them the obvious partner of choice for Brain Matters as we continue to expand our business.”

ERG is the largest independent site company in the U.S. focused in neuroscience drug development. Several of its portfolio sites are conducting studies in Alzheimer’s disease with the most active being Pacific Research Network (PRN) in San Diego, founded by Dr. Stephen Thein, another leader in the field of dementia research. Dr. Thein, commented, "I have known Mark Brody for over 15 years and have worked alongside him in multiple clinical trials and on several advisory boards.  He is a well-respected leader in the field of Alzheimer's research has dedicated his life to his patients.”

ERG’s Chief Executive Officer, Lori Wright shares Thein’s enthusiasm, stating “BMR’s excellent reputation in the industry for delivering quality data in neurological trials, and more specifically in the field of Alzheimer’s disease research, adds tremendous value to ERG’s established leadership position in the field of neuroscience research.” ERG’s acquisition strategy is to target CNS Sites with strong operational expertise, providing a firm platform for future growth. Ms. Wright added “BMR’s highly trained and fiery loyal staff was a key consideration in our decision and consistent with prior acquisitions all staff will be retained and continue to provide the same level of quality research studies to new and existing clients.

Brain Matters Research is one of nine (9) portfolio research units owned and operated by ERG. Evolution Research Group is the largest, privately-held clinical research site company in the United States.

Learn more about ERG by visiting

About Evolution Research Group
Evolution Research Group, LLC is comprised of nine fully owned and operated CRUs, Thievon-Wright Consulting Group and an established affiliate network of ten clinical research sites. ERG is the leading CNS network conducting simple and highly complex trials in specialized populations including psychiatric and neurologic disorders, sleep disorders, addictions, renal insufficiency and hepatic impairment as well as normal healthy volunteers.

Jeanine M. Estrada
Evolution Research Group
(908) 280-8128
email us here